- Home
- ARLO vs ETNB Comparison
ARLO vs ETNB Comparison
Compare ARLO & ETNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARLO
- ETNB
- Stock Information
- Founded
- ARLO 2018
- ETNB 2018
- Country
- ARLO United States
- ETNB United States
- Employees
- ARLO N/A
- ETNB N/A
- Industry
- ARLO Consumer Electronics/Appliances
- ETNB Biotechnology: Pharmaceutical Preparations
- Sector
- ARLO Consumer Staples
- ETNB Health Care
- Exchange
- ARLO Nasdaq
- ETNB Nasdaq
- Market Cap
- ARLO 1.1B
- ETNB 1.0B
- IPO Year
- ARLO 2018
- ETNB 2019
- Fundamental
- Price
- ARLO $14.35
- ETNB $10.10
- Analyst Decision
- ARLO Strong Buy
- ETNB Strong Buy
- Analyst Count
- ARLO 2
- ETNB 8
- Target Price
- ARLO $21.00
- ETNB $26.43
- AVG Volume (30 Days)
- ARLO 856.7K
- ETNB 2.1M
- Earning Date
- ARLO 05-08-2025
- ETNB 05-01-2025
- Dividend Yield
- ARLO N/A
- ETNB N/A
- EPS Growth
- ARLO N/A
- ETNB N/A
- EPS
- ARLO N/A
- ETNB N/A
- Revenue
- ARLO $505,752,000.00
- ETNB N/A
- Revenue This Year
- ARLO $4.00
- ETNB N/A
- Revenue Next Year
- ARLO $7.69
- ETNB N/A
- P/E Ratio
- ARLO N/A
- ETNB N/A
- Revenue Growth
- ARLO 0.27
- ETNB N/A
- 52 Week Low
- ARLO $7.84
- ETNB $4.16
- 52 Week High
- ARLO $17.64
- ETNB $11.84
- Technical
- Relative Strength Index (RSI)
- ARLO 77.82
- ETNB 61.20
- Support Level
- ARLO $13.26
- ETNB $8.94
- Resistance Level
- ARLO $13.71
- ETNB $9.89
- Average True Range (ATR)
- ARLO 0.44
- ETNB 0.68
- MACD
- ARLO 0.02
- ETNB 0.11
- Stochastic Oscillator
- ARLO 94.57
- ETNB 71.75
About ARLO Arlo Technologies Inc.
Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. It combines a cloud infrastructure and mobile app with various smart connected devices to provide users with visibility, insight, and a means to help protect and connect in real-time with the people and things from any location with a Wi-Fi or a cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).